These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 33216958)

  • 21. A case of splenomegaly in CBL syndrome.
    Coe RR; McKinnon ML; Tarailo-Graovac M; Ross CJ; Wasserman WW; Friedman JM; Rogers PC; van Karnebeek CDM
    Eur J Med Genet; 2017 Jul; 60(7):374-379. PubMed ID: 28414188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exon 8 splice site mutations in the gene encoding the E3-ligase CBL are associated with core binding factor acute myeloid leukemias.
    Abbas S; Rotmans G; Löwenberg B; Valk PJ
    Haematologica; 2008 Oct; 93(10):1595-7. PubMed ID: 18698078
    [No Abstract]   [Full Text] [Related]  

  • 23. CBL exon 8/9 mutants activate the FLT3 pathway and cluster in core binding factor/11q deletion acute myeloid leukemia/myelodysplastic syndrome subtypes.
    Reindl C; Quentmeier H; Petropoulos K; Greif PA; Benthaus T; Argiropoulos B; Mellert G; Vempati S; Duyster J; Buske C; Bohlander SK; Humphries KR; Hiddemann W; Spiekermann K
    Clin Cancer Res; 2009 Apr; 15(7):2238-47. PubMed ID: 19276253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel c-CBL and CBL-b ubiquitin ligase mutations in human acute myeloid leukemia.
    Caligiuri MA; Briesewitz R; Yu J; Wang L; Wei M; Arnoczky KJ; Marburger TB; Wen J; Perrotti D; Bloomfield CD; Whitman SP
    Blood; 2007 Aug; 110(3):1022-4. PubMed ID: 17475912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. De novo mutations in CBL causing early-onset paediatric moyamoya angiopathy.
    Guey S; Grangeon L; Brunelle F; Bergametti F; Amiel J; Lyonnet S; Delaforge A; Arnould M; Desnous B; Bellesme C; Hervé D; Schwitalla JC; Kraemer M; Tournier-Lasserve E; Kossorotoff M
    J Med Genet; 2017 Aug; 54(8):550-557. PubMed ID: 28343148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clonal selection of 11q CN-LOH and CBL gene mutation in a serially studied patient during MDS progression to AML.
    Barresi V; Palumbo GA; Musso N; Consoli C; Capizzi C; Meli CR; Romano A; Di Raimondo F; Condorelli DF
    Leuk Res; 2010 Nov; 34(11):1539-42. PubMed ID: 20674974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myelodysplastic features in a patient with germline CEBPA-mutant acute myeloid leukaemia.
    Yan B; Ng C; Moshi G; Ban K; Lee PL; Seah E; Chiu L; Koay ES; Liu TC; Ng CH; Chng WJ; Koh LP
    J Clin Pathol; 2016 Jul; 69(7):652-4. PubMed ID: 27010436
    [No Abstract]   [Full Text] [Related]  

  • 28. Identification of CBL, a proto-oncogene at 11q23.3, as a novel MLL fusion partner in a patient with de novo acute myeloid leukemia.
    Fu JF; Hsu JJ; Tang TC; Shih LY
    Genes Chromosomes Cancer; 2003 Jun; 37(2):214-9. PubMed ID: 12696071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. UBASH3B/Sts-1-CBL axis regulates myeloid proliferation in human preleukemia induced by AML1-ETO.
    Goyama S; Schibler J; Gasilina A; Shrestha M; Lin S; Link KA; Chen J; Whitman SP; Bloomfield CD; Nicolet D; Assi SA; Ptasinska A; Heidenreich O; Bonifer C; Kitamura T; Nassar NN; Mulloy JC
    Leukemia; 2016 Mar; 30(3):728-39. PubMed ID: 26449661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CBL mutations in juvenile myelomonocytic leukemia and pediatric myelodysplastic syndrome.
    Shiba N; Kato M; Park MJ; Sanada M; Ito E; Fukushima K; Sako M; Arakawa H; Ogawa S; Hayashi Y
    Leukemia; 2010 May; 24(5):1090-2. PubMed ID: 20357823
    [No Abstract]   [Full Text] [Related]  

  • 31. Immune dysregulation associated with co-occurring germline CBL and SH2B3 variants.
    Baccelli F; Leardini D; Muratore E; Messelodi D; Bertuccio SN; Chiriaco M; Cancrini C; Conti F; Castagnetti F; Pedace L; Pession A; Yoshimi A; Niemeyer C; Tartaglia M; Locatelli F; Masetti R
    Hum Genomics; 2022 Sep; 16(1):40. PubMed ID: 36123612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CBL mutation-related patterns of phosphorylation and sensitivity to tyrosine kinase inhibitors.
    Makishima H; Sugimoto Y; Szpurka H; Clemente MJ; Ng KP; Muramatsu H; O'Keefe C; Saunthararajah Y; Maciejewski JP
    Leukemia; 2012 Jul; 26(7):1547-54. PubMed ID: 22246246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CBL mutations in infant acute lymphoblastic leukaemia.
    Shiba N; Park MJ; Taki T; Takita J; Hiwatari M; Kanazawa T; Sotomatsu M; Ishii E; Arakawa H; Ogawa S; Hayashi Y
    Br J Haematol; 2012 Mar; 156(5):672-4. PubMed ID: 21988239
    [No Abstract]   [Full Text] [Related]  

  • 34. Acquired expression of
    Nakata Y; Ueda T; Nagamachi A; Yamasaki N; Ikeda KI; Sera Y; Takubo K; Kanai A; Oda H; Sanada M; Ogawa S; Tsuji K; Ebihara Y; Wolff L; Honda ZI; Suda T; Inaba T; Honda H
    Blood; 2017 Apr; 129(15):2148-2160. PubMed ID: 28209720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term survival after nonintensive chemotherapy in some juvenile myelomonocytic leukemia patients with CBL mutations, and the possible presence of healthy persons with the mutations.
    Matsuda K; Taira C; Sakashita K; Saito S; Tanaka-Yanagisawa M; Yanagisawa R; Nakazawa Y; Shiohara M; Fukushima K; Oda M; Honda T; Nakahata T; Koike K
    Blood; 2010 Jul; 115(26):5429-31. PubMed ID: 20595524
    [No Abstract]   [Full Text] [Related]  

  • 36. Somatic CBL mutation presenting as juvenile myelomonocytic leukemia with vasculitis.
    Mishra V; Krishnan VP; Desai M; Manek H; Pandrowala A; Bodhanwala M; Hiwarkar P
    Pediatr Blood Cancer; 2023 Jun; 70(6):e30252. PubMed ID: 36786373
    [No Abstract]   [Full Text] [Related]  

  • 37. Acquired uniparental disomy and c-CBL mutation in myelodysplastic syndromes.
    Sanada M
    Rinsho Ketsueki; 2011 Jun; 52(6):342-9. PubMed ID: 21737985
    [No Abstract]   [Full Text] [Related]  

  • 38. SETBP1 mutations in juvenile myelomonocytic leukaemia and myelodysplastic syndrome but not in paediatric acute myeloid leukaemia.
    Shiba N; Ohki K; Park MJ; Sotomatsu M; Kudo K; Ito E; Sako M; Arakawa H; Hayashi Y
    Br J Haematol; 2014 Jan; 164(1):156-9. PubMed ID: 24117422
    [No Abstract]   [Full Text] [Related]  

  • 39. Gain-of-function c-CBL mutations associated with uniparental disomy of 11q in myeloid neoplasms.
    Ogawa S; Sanada M; Shih LY; Suzuki T; Otsu M; Nakauchi H; Koeffler HP
    Cell Cycle; 2010 Mar; 9(6):1051-6. PubMed ID: 20237427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and molecular features of
    Yoshida T; Muramatsu H; Wakamatsu M; Sajiki D; Murakami N; Kitazawa H; Okamoto Y; Taniguchi R; Kataoka S; Narita A; Hama A; Okuno Y; Takahashi Y
    Haematologica; 2023 Nov; 108(11):3115-3119. PubMed ID: 37226702
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.